Detalles de la búsqueda
1.
The simplified follicular lymphoma PRIMA-prognostic index is useful in patients with first-line chemo-free rituximab-based therapy.
Br J Haematol
; 191(5): 738-747, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32410260
2.
M7-FLIPI is not prognostic in follicular lymphoma patients with first-line rituximab chemo-free therapy.
Br J Haematol
; 188(2): 259-267, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31423576
3.
Absolute B cell counts in blood predict long-term response in follicular lymphoma patients treated with rituximab without chemotherapy.
Ann Hematol
; 99(10): 2357-2366, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32808106
4.
Antibody response to COVID-19 mRNA vaccine (Comirnaty) in myeloma patients treated with high-dose melphalan and/or immunotherapy.
Am J Hematol
; 96(11): E443-E446, 2021 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34524709
5.
A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy.
Haematologica
; 104(10): e460-e464, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30846496
6.
Health-related quality of life and chronic fatigue in long-term survivors of indolent lymphoma - a comparison with normative data.
Leuk Lymphoma
; 64(2): 349-355, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36342349
7.
Minimal residual disease status is the prognostic determinant following high-dose treatment for patients with multiple myeloma.
Cancer Med
; 12(22): 20736-20744, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37921243
8.
Survival by First-line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population-based Study in Sweden.
Hemasphere
; 7(3): e838, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36844185
9.
Primary refractory follicular lymphoma: a poor outcome entity with high risk of transformation to aggressive B cell lymphoma.
Eur J Cancer
; 157: 132-139, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34508995
10.
Chemotherapy-Free Initial Treatment of Advanced Indolent Lymphoma Has Durable Effect With Low Toxicity: Results From Two Nordic Lymphoma Group Trials With More Than 10 Years of Follow-Up.
J Clin Oncol
; : JCO1800262, 2018 Oct 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30285560
11.
Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment.
Hemasphere
; 7(4): e863, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37038467
12.
Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis.
Lancet Haematol
; 5(8): e359-e367, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30078408
13.
Reply to M. Sorigue et al.
J Clin Oncol
; 37(9): 759-760, 2019 03 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30735430
Resultados
1 -
13
de 13
1
Próxima >
>>